概括
在初级胆道硬化 (PBC) 患者中,乌尔索多胆酸 (UDCA) 治疗改善了肝功能,减少了. 长期的UDCA治疗似乎是安全和有效的,需要进一步进行受控试验.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
- 临床药理学 临床药理学
背景情况:
- 初级胆管缩 (PBC) 是一种慢性肝病,其特点是胆管逐渐破坏.
- 目前对PBC的治疗有局限性,需要探索新的治疗药物.
- 乌尔苏多氧胆酸 (UDCA) 是一种天然存在的胆汁酸,具有潜在的肝脏保护性质.
研究的目的:
- 为了前性地评估长期的ursodeoxycholic acid (UDCA) 治疗在患有原发性胆道硬化 (PBC) 的患者中的疗效和安全性.
主要方法:
- 一项前性研究涉及15名患有PBC的患者,每天接受UDCA (13-15 mg/kg体重).
- 血清UDCA度,总胆酸水平,的严重程度和标准肝功能测试在2年内进行了监测.
- 在三个患者中,经过3个月的中断和随后的UDCA恢复后,重新评估了肝功能.
主要成果:
- 血清UDCA度显著增加,而总胆汁酸保持不变.
- 需要胆固醇胺的明显减少,标准肝功能测试显示明显改善.
- 停用UDCA导致肝功能测试的恶化,在药物恢复后得到改善.
结论:
- 长期的ursodeoxycholic acid (UDCA) 治疗似乎是一种安全有效的选择,用于管理原发性胆道硬化 (PBC).
- UDCA在改善肝功能测试和缓解PBC患者的方面显示出显著的益处.
- 建议通过随机,受控,双盲试验进行进一步的调查,以证实这些发现.
相关概念视频
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:21Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment: